Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2025Rheumatology Advances in PracticeOpen Access

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope

View Full Paper
Ask AI
Bookmark
Share

Authors

SLStephanie F LingManchester Academic Health Science CentreJBJoshua BennettSouthampton General HospitalVRVanessa Reid

Discussion

Loading...

Member takes

Implication

New guidelines emphasize safety for biologic and targeted synthetic DMARDs in children with inflammatory arthritis, suggesting recent pharmacotherapy updates.

Key Points

  • Guidelines promote safe use of biologic and targeted synthetic DMARDs for inflammatory arthritis patients.
  • Newer pharmacotherapies, including Janus kinase inhibitors, are now included in the updated recommendations.
  • Scope expands to include children and young people with inflammatory arthritis for the first time.
  • Updates follow the British Society for Rheumatology's rigorous clinical guideline development protocol.

Cite This Study

Ling et al. (2025) studied this question.

synapsesocial.com/papers/68f04935e559138a1a06e4echttps://doi.org/10.1093/rap/rkaf104
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update2024 · 375 citations
  2. 2Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study2023 · 9 citations
  3. 32021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging2022 · 48 citations
  4. 4The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis2018 · 185 citations
  5. 5British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids2022 · 234 citations